ALBERTA

Canadian Natural Resources Limited Announces Normal Course Issuer Bid

Retrieved on: 
Friday, March 8, 2024

Calgary, Alberta--(Newsfile Corp. - March 8, 2024) - Canadian Natural Resources Limited (TSX: CNQ) (NYSE: CNQ) ("Canadian Natural") announced today that the Toronto Stock Exchange ("TSX") has accepted notice filed by Canadian Natural of its intention to make a Normal Course Issuer Bid ("NCIB") through the facilities of the TSX or other alternative Canadian trading systems.

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - March 8, 2024) - Canadian Natural Resources Limited (TSX: CNQ) (NYSE: CNQ) ("Canadian Natural") announced today that the Toronto Stock Exchange ("TSX") has accepted notice filed by Canadian Natural of its intention to make a Normal Course Issuer Bid ("NCIB") through the facilities of the TSX or other alternative Canadian trading systems.
  • The price which Canadian Natural will pay for any such shares will be the market price at the time of acquisition.
  • The actual number of common shares that may be purchased and the timing of any such purchases will be determined by Canadian Natural.
  • In connection with the NCIB, Canadian Natural expects to enter into an automatic share purchase plan ("ASPP") in relation to purchases made under the NCIB.

Zenith Epigenetics Proudly Supports Rare Disease Day

Retrieved on: 
Thursday, February 29, 2024

ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - February 29, 2024) - Zenith Epigenetics Ltd. ("Zenith" or the "Company") announces its support of Rare Disease Day by highlighting our expanded development efforts of BET inhibitor ZEN-3694 for rare oncology diseases.
  • Rare Disease Day takes place every year on the last day of February, with this leap year day being the rarest of all Rare Disease Days.
  • This event is a global movement to promote equity in healthcare, and access to diagnosis and therapies for individuals living with rare diseases.
  • We are very pleased that NUT carcinoma patients receiving ZEN-3694 in clinical trial and compassionate use settings have benefitted from our drug," said Donald McCaffrey, CEO of Zenith Epigenetics.

Canadian Natural Resources Limited Announces Quarterly Dividend

Retrieved on: 
Thursday, February 29, 2024

Calgary, Alberta--(Newsfile Corp. - February 29, 2024) - Canadian Natural Resources Limited (TSX: CNQ) (NYSE: CNQ) announces that its Board of Directors approved a 5% increase to its quarterly cash dividend on its common shares to C$1.05 (One dollar and five cents) per common share.

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - February 29, 2024) - Canadian Natural Resources Limited (TSX: CNQ) (NYSE: CNQ) announces that its Board of Directors approved a 5% increase to its quarterly cash dividend on its common shares to C$1.05 (One dollar and five cents) per common share.
  • The dividend will be payable on April 5, 2024 to shareholders of record at the close of business on March 15, 2024.
  • Since March 2, 2023, the Company has increased its quarterly dividend 24% through three separate increases for a combined increase of $0.20 per common share.
  • Canadian Natural is a senior crude oil and natural gas production company, with continuing operations in its core areas located in Western Canada, the U.K. portion of the North Sea and Offshore Africa.

Grizzly Discoveries Inc. Exhibiting at Booth 3020, PDAC 2024 Convention in Toronto, March 3-6

Retrieved on: 
Tuesday, February 27, 2024

Edmonton, Alberta--(Newsfile Corp. - February 27, 2024) - Visit Grizzly Discoveries Inc. (TSXV: GZD) (OTCQB: GZDIF) at Booth #3020 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Key Points: 
  • Edmonton, Alberta--(Newsfile Corp. - February 27, 2024) - Visit Grizzly Discoveries Inc. (TSXV: GZD) (OTCQB: GZDIF) at Booth #3020 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Pacylex to Meet with Investors at Bio CEO Conference (BCIC) in New York City, February 26-27, 2024

Retrieved on: 
Friday, February 23, 2024

The company's lead candidate, zelenirstat, is a first-in-class, orally bioavailable small molecule myristoylation inhibitor, a new mechanism of action for cancer treatment.

Key Points: 
  • The company's lead candidate, zelenirstat, is a first-in-class, orally bioavailable small molecule myristoylation inhibitor, a new mechanism of action for cancer treatment.
  • Zelenirstat is currently being studied in patients who have failed available treatments (refractory or relapsed; r/r).
  • If you are attending BIO CEO & Investors, we would like to talk to you about investing in Pacylex and zelenirstat, a first-in-class oral cancer drug in Phase 2.
  • Zelenirstat has a great safety profile and evidence of benefit in refractory patients with solid and liquid tumors.

You're invited to join NAIT Applied Research and NAIT Corporate & Continuing Education at PDAC 2024 Convention in Toronto

Retrieved on: 
Thursday, February 22, 2024

Edmonton, Alberta--(Newsfile Corp. - February 22, 2024) - Visit NAIT Applied Research and NAIT Corporate & Continuing Education at Booth #6132N at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Key Points: 
  • Edmonton, Alberta--(Newsfile Corp. - February 22, 2024) - Visit NAIT Applied Research and NAIT Corporate & Continuing Education at Booth #6132N at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Tourism Jasper Is a Proud Participant in an Upcoming Episode of Hit Reality Series "The Bachelor"

Retrieved on: 
Tuesday, February 20, 2024

Tune in Monday, February 26th, at 8/7c on ABC and stream next day on Hulu

Key Points: 
  • Jasper, Alberta--(Newsfile Corp. - February 20, 2024) - Tourism Jasper is a proud participant in an upcoming episode of "The Bachelor."
  • The episode will feature romantic dates in the mountain town of Jasper at the luxurious and historic Fairmont Jasper Park Lodge with the newest Bachelor, Joey Graziadei.
  • This episode of "The Bachelor" will air Monday, February 26th, at 8/7c, on ABC and be available to stream the next day on Hulu.
  • As the Bachelor, Joey is looking for a life partner who is outgoing, caring and shares his love for adventure and exploring the outdoors.

Copper Fox Metals Inc.: Visit us at PDAC 2024 Convention in Toronto this March at Booth 2713

Retrieved on: 
Monday, February 19, 2024

Calgary, Alberta--(Newsfile Corp. - February 19, 2024) - Visit Copper Fox Metals Inc. (TSXV: CUU) (OTCQX: CPFXF) at Booth #2713 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Key Points: 
  • Calgary, Alberta--(Newsfile Corp. - February 19, 2024) - Visit Copper Fox Metals Inc. (TSXV: CUU) (OTCQX: CPFXF) at Booth #2713 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

NevGold Announces Closing of Shares-For-Debt Transaction

Retrieved on: 
Tuesday, March 12, 2024

Vancouver, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce the closing of a previously-announced shares for debt transaction, as described in the press release of the Company dated February 16, 2024 (the “Shares-for-Debt Transaction”).

Key Points: 
  • Vancouver, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce the closing of a previously-announced shares for debt transaction, as described in the press release of the Company dated February 16, 2024 (the “Shares-for-Debt Transaction”).
  • NevGold has settled debt in the amount of C$135,000 (the “Debt”) previously owed to an arm’s-length creditor by issuing an aggregate of 421,875 common shares in the capital of the Company (the “Common Shares”) at a price of $0.32 per Common Share to the creditor.
  • The Company has received TSX Venture Exchange approval of the Shares-for-Debt Transaction.
  • The Common Shares issued pursuant to the Shares-for-Debt Transaction are subject to a four month hold period expiring on July 12, 2024.